Context and Objectives: Low birthweight (LBW) has emerged as a risk factor of metabolic syndrome (MetS). Whether adults with very low birthweight (VLBW) born preterm are at higher risk than individuals who were term-born small for gestational age (tb-SGA) is not established. We assessed metabolic outcomes, including relation with skeletal parameters, in these two LBW categories.
syndrome (1) . Worldwide, the estimated prevalence is ;25% (2) .
Low birthweight (LBW) and prematurity have emerged as risk factors for metabolic syndrome (3) (4) (5) (6) (7) . Globally, around 15 million preterm births occur annually (8) , and the survival rate is now close to 90% (9) . A substantial number are also born small for gestational age at term (tb-SGA) (10) . Most studies have addressed the metabolic profile in individuals with LBW born premature (5-7, 11, 12) or without a specified gestational age (13, 14) . Adults born very preterm or at very low birthweight (VLBW) have been reported to exhibit higher blood pressure (BP) than term-born adults with normal weight (15, 16) . A meta-analysis showed that preterm birth was associated with higher BP (12) .
A relationship between metabolic syndrome and skeletal health has been suggested (17, 18) , and both positive and negative associations with bone mineral density (BMD) have been reported (19) (20) (21) . In line with previous studies, we have shown that adults with VLBW display inferior BMD (22) (23) (24) . The associations between metabolic syndrome and bone parameters, however, have not been explored in this population.
We aimed to study the metabolic risk profile in three groups of adults aged 26 to 28 years, born preterm with VLBW, tb-SGA, and with normal weight at term. Furthermore, we wanted to explore associations between metabolic and skeletal parameters, including trabecular bone score (TBS), a measure of bone quality.
Methods

Participants
This study was a part of a long-term multidisciplinary follow-up study of two cohorts comprising white individuals born 1986 to 1988: preterm with VLBW (,37 weeks, #1500 g), tb-SGA ($37 weeks, birthweight , 10th percentile), and a control group born at term ($37 weeks, birthweight $10th percentile), described in detail earlier (15, 24) . Exclusion criteria at birth were congenital syndromes and malformations (15) . At 26 to 28 years of age, 300 individuals were eligible and invited to participate in studies addressing bone health (24) and metabolic syndrome (Supplemental Fig. 1 ). Moderate to severe cerebral palsy, mental retardation, and pregnancy were exclusion criteria. Three individuals with VLBW and mild cerebral paresis, who were excluded in our previous study of bone health, were included in the current study. Main outcomes were measures of metabolic syndrome: waist circumference, BP, highdensity lipoprotein (HDL) cholesterol, triglycerides, and fasting blood glucose. The study was conducted between June 2013 and September 2014 at St. Olavs University Hospital, Trondheim, Norway. The study protocol was approved by the Regional Committee for Medical and Health Research Ethics in Central Norway (No: 2013/ 636/REK midt). All participants provided written informed consent.
Clinical data
A questionnaire addressing smoking habits, physical activity, medical conditions, and current medication was completed.
Body weight, height, waist circumference (midway between the last costal margin and the iliac crest in the midaxillary line), and hip circumference (at the maximum protuberance of the buttocks) were measured. Body mass index (BMI) and waist-to-hip ratio were calculated. Skinfold thickness was measured at the left triceps and subscapular region with a Harpenden skin folder caliper, and the ratio was calculated. BP measurements were conducted, between 0900 and 1100 hours, after a 5-minute rest in a seated position with an automated self-inflating sphygmomanometer (Criticare 506N; Criticare System, Inc., Waukesha, WI) taking the average of three readings. Investigators were blinded to group affiliation.
Fat and lean mass; BMD at spine, total hip, and femoral neck; and spine TBS were assessed by dual-energy x-ray absorptiometry, applying Hologic Discovery A S/N 83817 (software version 13.4.2; Hologic, Bedford, MA). Data on BMD and TBS have previously been reported on the majority of the study population (24) .
Biochemical parameters
Overnight fasting blood samples were collected. Glycated hemoglobin (HbA1c) was measured in full blood. Glucose, total and HDL cholesterol, triglycerides, cortisol, adrenocorticotropic hormone, 25-hydroxyvitamin D, homocysteine, and high-sensitive C-reactive protein were analyzed in plasma, and folate in serum, at the Department of Biochemistry, St. Olavs University Hospital. Insulin and C-peptide were measured with radioimmunoassays (Millipore, St. Charles, MO) and leptin, adiponectin, TNF-a, interleukin-6, and Dickkopf-1 by multianalyte profiling Milliplex MAP assays (Millipore, Billerica, MA) at our research laboratory; the intra-assay and interassay coefficients of variation were ,10% and ,15%, respectively. All analyses were performed according to the manufacturers' instructions. The Homeostatic Model Assessment 2 (HOMA2), version 2013 (University of Oxford, Oxford, UK), was used for calculation of insulin resistance (HOMA2-IR) and insulin sensitivity (HOMA2-IS) based on fasting C-peptide and fasting glucose levels. Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald formula modified by DeLong et al. (25) .
Metabolic syndrome criteria
Metabolic syndrome was defined according to the Joint Interim Statement (2009) (1) as having any three of the following: central obesity (waist circumference $94 cm in men and $80 cm in women); triglycerides $1.7 mmol/L; HDL cholesterol ,1.03 mmol/L in males, ,1.29 mmol/L in females, or on treatment for these dyslipidemias; systolic BP (SBP) $130 mm Hg, diastolic BP (DBP) $85 mm Hg, or on treatment for hypertension; and fasting plasma glucose $5.6 mmol/L, previously diagnosed type 2 diabetes, or on treatment for diabetes.
Metabolic syndrome score was assessed in accordance with Viitasalo et al. (26) , using the following equation: metabolic syndrome score = waist circumference + (SBP + DBP)/2 -HDL cholesterol log + fasting plasma glucose log + triglycerides log. 
Statistical analyses
Adjustments
A univariate, general linear model was applied to adjust for potential confounders (adult weight, height, physical activity, and smoking). When correcting waist circumference for each of these factors separately, smoking did not affect the group differences and therefore was not included as a confounder. Likewise, waist-to-hip ratio was not influenced by adjustment of height and physical activity, and these factors were omitted in the analysis. Differences in BP and serum parameters were not altered after adjustment for these potential confounders (data not shown). Only crude data are presented in the tables.
Results
Clinical characteristics
In total, 189 individuals (females, n = 96, 51%) were included, comprising 55 VLBW, 59 tb-SGA, and 75 control participants (Supplemental Fig. 1 ). As described earlier, chronic diseases were uncommon in our study population and did not differ between the groups (24). None had diabetes, and one control participant was treated for hypertension.
Sex distribution, birthweight, and gestational age were similar between participants and nonparticipants (data not shown). Characteristics of the study population are presented in Table 1 . Adults with VLBW were less physically active than controls. Tables 2 and 3 show crude data on indices of metabolic syndrome and associated parameters in the total population and by sex stratification, respectively. Fig. 1 shows between-group differences in the five indices of metabolic syndrome. Waist circumference and waist-to-hip ratio were similar. After adjustment for adult weight, height, and physical activity, waist circumference [mean (SD), 85.79 (0.58) vs 83.99 (0.51) cm, P = 0.02] was higher in individuals with tb-SGA compared with controls. Similarly, waist-to-hip ratio was higher in this group after correction for weight and smoking lower BMD at femoral neck, total hip, and whole body compared with controls, whereas TBS was similar between the groups. The participants with VLBW comprised individuals who were born small, appropriate, or large for gestational age. A subgroup analysis did not reveal any differences in BMI, waist circumference, waist-to-hip ratio, and BP between these groups (data not shown).
Biochemical parameters
Data are presented in Table 2 , Table 3 When stratifying for sex, differences in HDL cholesterol levels were seen only between females with VLBW and control females. The individuals who were tb-SGA had significantly higher total cholesterol and LDL cholesterol; these differences were confined to females who were tb-SGA compared with control females. Individuals with VLBW demonstrated higher HbA1c and C-peptide, as well as increased HOMA2-IR and reduced HOMA2-IS compared with controls. Males with VLBW displayed higher fasting glucose [mean (SD), 5.10 (0.46) vs 4.98 (0.37) mmol/L, P = 0.04] and HbA1c [5.30% (0.2%) vs 5.05% (0.3%), P = 0.04] than did control males. The males who were tb-SGA had higher fasting glucose compared with control males [mean (SD), 5.30 (0.58) vs 4.98 (0.37) mmol/L, P = 0.004]. Serum 25-hydroxyvitamin D levels did not differ between the groups but were lower in females with VLBW than in control and females who were tb-SGA.
The tb-SGA and VLBW groups demonstrated higher homocysteine levels; the latter also exhibited lower folate levels compared with controls. The females who were tb-SGA displayed higher cortisol levels than did females with VLBW. Adrenocorticotropic hormone, high-sensitive C-reactive protein, leptin, adiponectin, interleukin-6, and TNF-a were similar between the groups. Dickkopf-1 levels were higher in adults with VLBW compared with controls. (Supplemental Table 2 ).
Metabolic syndrome
Metabolic syndrome was present in 9.5% (18/189) of the study population and predominantly in males (n = 12: two controls, six tb-SGA, four VLBW). It was more frequent among individuals with VLBW (13%, 7/54) than in controls (7%, 5/74) and individuals who were tb-SGA (10%, 6/59), although not significant. At least one component of the syndrome was present in a higher proportion of adults with VLBW compared with controls (72%, 39/54 vs 55%, 41/74, P = 0.048), whereas the individuals who were tb-SGA did not differ (61%, 36/59, P = 0.56). The significant difference was confined to females with VLBW vs control females (79%, 22/28 vs 50%, 20/40, P = 0.016). Females with VLBW had a higher metabolic score than control and females who were tb-SGA, whereas no difference was observed between males (Table 3) .
Associations
SBP and DBP correlated negatively with gestational age (r = 20.19, P = 0.01 and r = 20.18, P = 0.02, respectively). A reduction of 0.44 and 0.24 mm Hg occurred in SBP and DBP, respectively, with each week increase in gestational age. Metabolic syndrome score correlated negatively with gestational age (r = 20.16, P = 0.03) and fell by 0.51 units for each week increase in gestational age (95% CI, 20.99 to 20.05).
We observed a positive correlation between metabolic syndrome score and spine and whole-body BMD and a negative correlation with TBS (Table 4) . Similar correlations were seen with all components of the metabolic syndrome, except for HDL cholesterol, which correlated inversely with BMD and positively with TBS (data not shown). Significant associations were noticed only in males. 25-Hydroxyvitamin D correlated inversely with metabolic syndrome score. Dickkopf-1 correlated positively with BMI and fat mass (Table 4) .
Discussion
In this longitudinal follow-up study, we show that both adults born preterm with VLBW and who were tb-SGA displayed an unfavorable metabolic profile compared with term-born controls. At least one component of the metabolic syndrome was present in a substantially higher proportion of the VLBW group. Metabolic syndrome was also more prevalent among adults with VLBW, although not significant. The more pronounced susceptibility to metabolic syndrome in the preterm group was reflected in a negative association between metabolic syndrome score and gestational age. Females with VLBW appeared to be at highest risk. In the total population, we observed a positive correlation between metabolic syndrome score and BMD, whereas TBS correlated negatively.
In accordance with previous studies (15, 16) , adults with VLBW, and preferentially females, showed higher SBP and DBP than did controls. Adjustment for physical activity and other confounding factors did not influence the differences observed in BP and mean arterial pressure. In a study by Howard et al. (27) , a 10-mm Hg difference in SBP was associated with an 8% increase in risk of stroke for whites vs a 24% increase for blacks. In young adulthood, DBP was found to be the most robust indicator of future CVD in white individuals (28) . Data from the Framingham study show that the CVD risk increases gradually with the BP, even within the normal range (29) . The higher BP, mean arterial pressure, and heart rate observed in the VLBW group may thus enhance the cardiovascular risk (1, 2).
In the current study, a decline in BP was observed with increasing gestational age. We observed no differences in BP between individuals with VLBW who were born small, appropriate, or large for gestational age. This is in line with Hovi et al. (16) , who concluded that the effects of VLBW birth override the influence of intrauterine growth restriction (IUGR) and degree of immaturity. Several mechanisms for the augmentation of BP have been proposed, including disturbance of fetal nephrogenesis (30) and inadequate synthesis of elastin (31) . Increased activity of the hypothalamic-pituitary-adrenal axis has also been suggested. Buske-Kirschbaum et al. (32) reported higher cortisol levels after awakening in preterm children compared with full-terms, but no between-group differences were observed in the short diurnal cortisol profile. In the current study, the VLBW group displayed the lowest cortisol levels. Our findings are in accordance with Kaseva et al. (33) , who observed blunted hypothalamic-pituitary-adrenal axis response in young adults born preterm with VLBW.
Central obesity is considered a hallmark of metabolic syndrome (34) . We observed higher waist circumference and waist-to-hip ratio in the tb-SGA group after adjustment. The higher skinfold thickness ratio in the VLBW group indicates more body fat. By means of magnetic resonance imaging, ectopic lipid deposition has been reported in adults with VLBW and with extremely low birthweight (35, 36) . We used dual-energy x-ray absorptiometry, which is a less sensitive method with respect to estimation of ectopic fat, for assessment of body composition. In contrast to Thomas et al. (35) , we observed no difference in whole-body fat. After sex stratification, lean mass was shown to be inferior among females in both low birthweight groups. Reduced muscle mass could contribute to a normal waist circumference despite excess visceral fat. Low muscle mass has also been reported to be associated with higher cardiometabolic risk (37) .
Insulin resistance is regarded as a key trait of metabolic syndrome (1). IUGR and slow infant growth have been linked to reduced b-cell mass (38) . Several studies indicate that adults born preterm or with VLBW have lower insulin sensitivity (7, 11, 22, 39) . The higher HbA1c and C-peptide levels observed in adults with VLBW in the current study suggest lower efficacy in the regulation of glucose metabolism. This could partly be attributed to insulin resistance, as indicated by the calculated HOMA2-IR and the HOMA2-IS parameters. An influence on glucose metabolism is also suggested in the tb-SGA group, exhibiting higher HbA1c and higher fasting glucose in male participants. Our findings are in line with a Danish population-based study that reported increased risk of type 2 diabetes in adults with low birthweight or born preterm (40) . Dyslipidemia is one of the most recognized components of the metabolic syndrome (34) . We observed lower HDL cholesterol concentrations among females with VLBW compared with control females and females who were tb-SGA, whereas females who were tb-SGA displayed higher LDL cholesterol than did controls. Furthermore, triglycerides were higher in both low birthweight groups, although nonsignificant. These findings may translate to increased susceptibility to CVD (1, 2, 34) .
The higher homocysteine levels observed in both low birthweight groups may reflect increased cardiovascular risk. Elevated homocysteine level has been regarded as an independent risk factor for CVD (41) , although the association remains controversial. Vitamin D has also been linked to cardiometabolic risk factors (42) and correlated inversely with metabolic syndrome score in the current study. We observed no differences in markers of inflammation, such as high-sensitive C-reactive protein and adipokines.
Adults with VLBW displayed slightly higher levels of Dickkopf-1, which is a particularly important promotor of adipogenesis and an inhibitor of bone formation (43) . In accordance with this, we found a positive correlation between Dickkopf-1 and fat mass and BMI.
A recent meta-analysis reported that metabolic syndrome was present in 5% to 7% of young adults (44) . This corresponds to the prevalence in term-born controls, whereas the occurrence in the low birthweight groups was twice as high, although not significant. At least one feature of the metabolic syndrome was present in a higher proportion of participants with VLBW compared with controls. This is of significance, as the presence of one component implies enhanced risk of metabolic syndrome in the future (45) . Females with VLBW appeared to be at greater risk, as also reflected in a higher metabolic syndrome score compared with control females.
We have previously shown that both the VLBW and tb-SGA groups have inferior peak bone mass (24) . Our findings comply with previous studies showing reduced peak bone mass in VLBW survivors (22, 23) . To our knowledge, this is the first study to address the relationship between metabolic syndrome and bone quality in young adults born with low birthweight. We applied TBS, which relates to bone microarchitecture and serves as a measure of bone quality. Interestingly, we observed an inverse correlation between metabolic syndrome score and TBS, as well as a positive correlation with BMD. Similar correlations were seen between separate components of the metabolic syndrome and bone parameters. When stratifying for sex, the significant correlations were confined to males. Our findings correspond to a study of overweight/obese men, where TBS correlated negatively with waist circumference and BMI and positively with BMD (46) . The same pattern is reported in individuals with type 2 diabetes exhibiting increased fracture risk despite normal or high BMD (47) . Our data suggest that constituents of the metabolic syndrome may be involved in the impairment of bone quality. The reason for this discrepancy between the sexes in the current study is not known, and the findings should be explored in larger studies.
The tb-SGA group is composed of both IUGR and constitutionally small individuals. Differentiation between these two is challenging. According to Ananth et al. (48) , infants who were tb-SGA are more likely to be constitutionally small. However, being born at term with birthweight less than the third percentile indicates IUGR (49) . In the current study, six individuals who were tb-SGA had a birthweight less than the third percentile, which may imply IUGR. According to this, most of the adults who were tb-SGA were presumably constitutionally small. It should, however, be kept in mind that the birthweight percentile only indicates the likelihood of having experienced IUGR, which in theory may occur at all birthweights depending on the prerestriction growth trajectory. Few studies have addressed future health in constitutionally small individuals. Rinaudo and Wang (50) claimed that they are not predisposed to long-term health consequences. Our data suggest, however, that adults who were tb-SGA may be at risk for metabolic syndrome independent of etiology. The major strength of the study is the access to population-based long-term follow-up cohorts of both sexes from birth to adulthood, minimizing selection bias. In contrast to most previous studies, gestational age was available in all participants. Although the sample size was small, an average attendance rate of .60% is acceptable in the context of long-term follow-up studies (51) . Furthermore, there were no significant differences in sex, birthweight, or gestational age between participants and nonparticipants. Limitations of the study include the lack of maternal data, including serial ultrasound examination, which would have eased differentiation between constitutionally small and growth-restricted participants. The small sample size makes it vulnerable to type 2 errors, and multiple testing contributes to a relatively high risk of type 1 errors. The findings should thus be interpreted with caution.
In conclusion, both low birthweight groups, particularly the females with VLBW, displayed a more unfavorable metabolic profile than did controls. The individuals who were tb-SGA seemed to be at increased risk, although the majority may be constitutionally small. The inferior bone quality in those with high metabolic syndrome score may imply increased future fracture risk.
